findmyKOL
Clinical trialNCT06854653RecruitingPhase 2Interventional

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

SponsorPrescient Therapeutics, Ltd.Enrollment115CTCL
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Westmead Hospital

    Westmead, New South Wales, Australia

    Ian Bilmon, MD
    Recruiting
  • Epworth Healthcare

    Melbourne, Victoria, Australia

    Miles Prince, MD
    Recruiting
  • Linear Clinical Research

    Nedlands, Western Australia, Australia

    Dejan Radeski, MD
    Recruiting
France
  • Chu de Bordeaux - Hopital Saint André

    Bordeaux, Bordeaux, France

    Marie Beylot-Barry, MD, PhD
    Not, yet, recruiting
  • Hopital Lyon Sud

    Lyon, Pierre-Benite, France

    Stephane Dalle, MD, PhD
    Not, yet, recruiting
  • Hopital Saint Louis

    Paris, Île-de-France Region, France

    Adele De Masson, MD
    Not, yet, recruiting
Italy
  • Irccs Azienda Ospedaliero Universitaria Di Bologna - Policlinico S. Orsola-Malpighi

    Bologna, Bologna, Italy

    Pier Luigi Zinzani, MD
    Recruiting
  • Universita Degli Studi Di Brescia-Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

    Brescia, Brescia, Italy

    Alessandra Tucci, MD
    Recruiting
  • Istituto Di Ricovero E Cura A Carattere Scientifico (irccs) - Ospedale San Raffaele (hsr) (istituto Scientifico Universitario San Raffaele)

    Milan, Milano, Italy

    Andres M J J. Ferreri, MD
    Recruiting
United States
  • City of Hope Comprehensive Cancer Cente

    Duarte, California, United States

    Christiane Querfeld, MD, PhD
    Recruiting
  • University of California Irvine

    Irvine, California, United States

    Lauren Pinter-Brown, MD
    Recruiting
  • Yale Cancer Center

    New Haven, Connecticut, United States

    Francine M Foss, MD
    Recruiting
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

    Eric Jacobsen, MD
    Recruiting
  • Rochester Skin Lymphoma Medical Group. Pllc

    Rochester, New York, United States

    Brian Poligone, MD, PhD
    Recruiting
  • Virginia Commonwealth University Massey Comprehensive Cancer Cente

    Richmond, Virginia, United States

    Bruce Hough, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Mar 2025
Primary completion
31 Jan 2028
Completion
30 Jun 2028
Last update posted
29 Apr 2026
Registered enrollment
115
Registry id
NCT06854653

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.